Implicity Earns Coveted Spot in the Plug and Play Cleveland Health Accelerator Program

By AIT News Desk On Apr 16, 2021

Remote Patient Monitoring and Cardiac Data Management Solution Provider Is One of Only Six Innovators Accepted Into the Batch 5 Program for Spring 2021

Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced the company has been selected to join Plug and Play Cleveland – one of the world’s largest accelerator programs. Implicity is among only six startups chosen from hundreds of startups around the globe to be accepted into the 12-week health program for Spring 2021.

Lightning AI Raises $50Million to Simplify and Scale AI Development For Enterprises and Developers

Nov 22, 2024

Teach Mode Is Here: rabbit Gives Consumers Power to Create Custom AI Agents

Nov 22, 2024

Lumina AI Welcomes Jason Sultz to Advisory Board to Strengthen AI and Advanced Compute Expertise

Nov 22, 2024

Prev Next 1 of 40,411

“We’re excited to work with the amazing network at Plug and Play,” said cardiac electrophysiologist, Dr. Arnaud Rosier, founder and CEO of Implicity. “Remote monitoring for cardiac devices is evolving rapidly, but to manage care more effectively requires a solution that can tie together patient-specific medical information from various sources and deliver contextual alerts. That’s a key benefit Implicity brings to the market.”

Implicity is already a leading solution in Europe for remote monitoring (RM) of patients with Cardiac Implantable Electronic Devices (CIEDs) – pacemakers, defibrillators, and implantable loop recorders. The cloud-based platform aggregates data from all CIEDs across manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic and Microport) and is designed to make the remote clinical workflow more efficient, and improve patient care outcomes. Implicity is also developing AI-based digital medical devices serving the future of preventive medicine. The company recently expanded into the United States via a partnership agreement with IronRod Health – where there are currently an estimated 5 million patients with CIEDs.